Cargando…
Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma
The present study aimed to identify serum biomarkers for the detection of hepatoblastoma (HB). Serum samples were collected from 71 HB patients (stage I, n = 19; stage II, n = 19, stage III, n = 19; and stage IV, n = 14) and 23 age- and sex-matched healthy children. Differential expression of serum...
Autores principales: | Zhao, Wei, Li, Juan, Zhang, Junjie, Gao, Pengfei, Pei, Hang, Wang, Lei, Guo, Fei, Yu, Jiekai, Zheng, Shu, Wang, Jiaxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490467/ https://www.ncbi.nlm.nih.gov/pubmed/26053398 http://dx.doi.org/10.3390/ijms160612669 |
Ejemplares similares
-
Identification of differentially expressed inflammatory factors in Wilms tumors and their association with patient outcomes
por: Guo, Fei, et al.
Publicado: (2017) -
Screening and identification of post-traumatic stress-related serum factors in children with Wilms' tumors
por: ZHANG, JUNJIE, et al.
Publicado: (2016) -
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma
por: Xie, Tan, et al.
Publicado: (2023) -
Glypican 3 as a Serum Marker for Hepatoblastoma
por: Zhou, Shengmei, et al.
Publicado: (2017) -
Identification of Apolipoprotein C-I as a Potential Wilms’ Tumor Marker after Excluding Inflammatory Factors
por: Zhang, Junjie, et al.
Publicado: (2014)